Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Trial register facet

Trial records reported in 2013 — page 2

39 records with a recorded report or completion year of 2013.

Showing 0 records on this page

Records

39 documents · page 2 of 2

Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.

RecordCompoundPhaseStatusDesignRandomisedYearCertainty
STEPS-2TeduglutidePhase 3ReportedSingle-arm open-label882013Moderate
STEPS-2-ADHERENCEprogramme recordTeduglutidePhase 3ReportedObservational2013Very low
STEPS-2-BIOMARKERprogramme recordTeduglutidePhase 3ReportedRandomised, double-blind, placebo-controlled2013Very low
STEPS-2-ELDERLYprogramme recordTeduglutidePhase 3ReportedRandomised, double-blind, placebo-controlled2013Very low
STEPS-2-OLEprogramme recordTeduglutidePhase 3ReportedSingle-arm open-label2013Very low
TA1-SEPSIS-CNThymosin alpha-1Phase 3ReportedRandomised, double-blind, placebo-controlled3612013Moderate
TA1-SEPSIS-CN-ADHERENCEprogramme recordThymosin alpha-1Phase 3ReportedObservational2013Very low
TA1-SEPSIS-CN-BIOMARKERprogramme recordThymosin alpha-1Phase 3ReportedRandomised, double-blind, placebo-controlled2013Very low
TA1-SEPSIS-CN-ELDERLYprogramme recordThymosin alpha-1Phase 3ReportedRandomised, double-blind, placebo-controlled2013Very low
TA1-SEPSIS-CN-OLEprogramme recordThymosin alpha-1Phase 3ReportedSingle-arm open-label2013Very low
TB4-PH2-VENOUSULCERThymosin beta-4Phase 2ReportedRandomised, double-blind, placebo-controlled722013Low
TB4-PH2-VENOUSULCER-ADHERENCEprogramme recordThymosin beta-4Phase 2ReportedObservational2013Very low
TB4-PH2-VENOUSULCER-BIOMARKERprogramme recordThymosin beta-4Phase 2ReportedRandomised, double-blind, placebo-controlled2013Very low
TB4-PH2-VENOUSULCER-ELDERLYprogramme recordThymosin beta-4Phase 2ReportedRandomised, double-blind, placebo-controlled2013Very low
TB4-PH2-VENOUSULCER-OLEprogramme recordThymosin beta-4Phase 2ReportedSingle-arm open-label2013Very low

page 2 of 2

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.